180 related articles for article (PubMed ID: 10198795)
1. Conjugated polysaccharide vaccines.
Ahmad H; Chapnick EK
Infect Dis Clin North Am; 1999 Mar; 13(1):113-33, vii. PubMed ID: 10198795
[TBL] [Abstract][Full Text] [Related]
2. Immune responses to polysaccharides: lessons from humans and mice.
González-Fernández A; Faro J; Fernández C
Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
[TBL] [Abstract][Full Text] [Related]
3. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
Blanchard-Rohner G; Pollard AJ
Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a pentavalent conjugated pneumococcal vaccine in toddlers.
Pichichero ME; Shelly MA; Treanor JJ
Pediatr Infect Dis J; 1997 Jan; 16(1):72-4. PubMed ID: 9002106
[No Abstract] [Full Text] [Related]
5. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.
Pollard AJ; Perrett KP; Beverley PC
Nat Rev Immunol; 2009 Mar; 9(3):213-20. PubMed ID: 19214194
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger.
Campagne G; Garba A; Fabre P; Schuchat A; Ryall R; Boulanger D; Bybel M; Carlone G; Briantais P; Ivanoff B; Xerri B; Chippaux JP
Pediatr Infect Dis J; 2000 Feb; 19(2):144-50. PubMed ID: 10694002
[TBL] [Abstract][Full Text] [Related]
7. [Bacterial polysaccharide vaccines: Meningococcus, Pneumococcus, Haemophilus influenzae].
Triau R
Rev Prat; 1984 Jun; 34(31):1683-90. PubMed ID: 6429835
[No Abstract] [Full Text] [Related]
8. Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland.
Mäkelä PH; Peltola H; Käyhty H; Jousimies H; Pettay O; Ruoslahti E; Sivonen A; Renkonen OV
J Infect Dis; 1977 Aug; 136 Suppl():S43-50. PubMed ID: 408432
[No Abstract] [Full Text] [Related]
9. Immunization of newborns with bacterial conjugate vaccines.
van den Biggelaar AH; Pomat WS
Vaccine; 2013 May; 31(21):2525-30. PubMed ID: 22728221
[TBL] [Abstract][Full Text] [Related]
10. Reactogenicity and immunogenicity of combined vaccines for bacteraemic diseases caused by Haemophilus influenzae type b, meningococci and pneumococci in 24-month-old children.
Eskola J; Käyhty H; Takala A; Rönnberg PR; Kela E; Peltola H
Vaccine; 1990 Apr; 8(2):107-10. PubMed ID: 2110703
[TBL] [Abstract][Full Text] [Related]
11. [Suppurative bacterial meningitis and the outlook for specific prevention].
Demina AA; Deviatkina NP
Zh Mikrobiol Epidemiol Immunobiol; 1984 May; (5):3-10. PubMed ID: 6429984
[No Abstract] [Full Text] [Related]
12. [Polysaccharide subunit vaccines].
Reinert P
Rev Prat; 1995 Jun; 45(12):1484-7. PubMed ID: 7660000
[TBL] [Abstract][Full Text] [Related]
13. Conjugate vaccines--a breakthrough in vaccine development.
Mäkelä PH
Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):249-53. PubMed ID: 12971544
[TBL] [Abstract][Full Text] [Related]
14. Capsular polysaccharides as human vaccines.
Jennings HJ
Adv Carbohydr Chem Biochem; 1983; 41():155-208. PubMed ID: 6195893
[No Abstract] [Full Text] [Related]
15. New bacterial vaccines.
Mäkelä PH
Pediatr Infect Dis; 1982; 1(5):291-4. PubMed ID: 6818533
[No Abstract] [Full Text] [Related]
16. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.
Shinefield HR; Black S; Ray P; Chang I; Lewis N; Fireman B; Hackell J; Paradiso PR; Siber G; Kohberger R; Madore DV; Malinowski FJ; Kimura A; Le C; Landaw I; Aguilar J; Hansen J
Pediatr Infect Dis J; 1999 Sep; 18(9):757-63. PubMed ID: 10493334
[TBL] [Abstract][Full Text] [Related]
18. Serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants.
Campbell H; Byass P; Ahonkhai VI; Vella PP; Greenwood BM
Pediatrics; 1990 Jul; 86(1):102-7. PubMed ID: 2113671
[TBL] [Abstract][Full Text] [Related]
19. Protein conjugate vaccines--how much is enough?
Obaro SK
Trends Microbiol; 2001 Aug; 9(8):364-5. PubMed ID: 11519529
[No Abstract] [Full Text] [Related]
20. Duration of serum anticapsular antibody after a two-dose regimen of a Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine and anamnestic response after a third dose.
Sood SK; Ballanco GA; Daum RS
J Pediatr; 1991 Oct; 119(4):652-4. PubMed ID: 1919901
[No Abstract] [Full Text] [Related]
[Next] [New Search]
